Endocrinology, Vol 133, 474-481, Copyright © 1993 by Endocrine Society

ARTICLES

Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation

KM Rosen, BM Wentworth, N Rosenthal and L Villa-Komaroff
Department of Neurology, Children's Hospital, Boston, Massachusetts.

We have compared the expression of insulin-like growth factor II (IGF- II) messenger RNA (mRNA) to the expression of other mRNAs encoding proteins known to play pivotal roles during the differentiation of continuously cultured, fusing muscle cell lines. These cell lines respond to changes in culture conditions by undergoing a well characterized alteration in gene expression which leads to a change in their phenotype from dividing, mononucleate myoblasts to fused, multinucleate myotubes. The hallmarks of this differentiation program include the induction of myogenic regulatory genes as well as the genes that encode the contractile proteins. We have found that the differentiation of these cells leads to the production of multiple IGF- II transcripts. In one of the cell lines studied, C2C12, IGF-II mRNA levels were rapidly induced during differentiation. Increases in IGF-II mRNA levels preceded the expression of the contractile protein genes but occurred only after the activation of the myogenic regulatory gene myogenin. The same regulated pattern of IGF-II mRNA expression was seen in both rapidly and slowly fusing subclones of this cell line, indicating a requirement for IGF-II at a specific point during muscle differentiation. These results suggest that IGF-II plays an important role during the terminal differentiation of skeletal muscle cells and are consistent with the existence of an autocrine loop through which IGF-II may act to regulate the differentiation process.

This article has been cited by other articles:

				K. Nakanishi, N. Dohmae, and N. Morishima Endoplasmic reticulum stress increases myofiber formation in vitro FASEB J, September 1, 2007; 21(11): 2994 - 3003. [Abstract] [Full Text] [PDF]

				M. Grohmann, E. Foulstone, G. Welsh, J. Holly, J. Shield, E. Crowne, and C. Stewart Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNF{alpha} J. Physiol., October 1, 2005; 568(1): 229 - 242. [Abstract] [Full Text] [PDF]

				S. N. Mehiri, E. Barreiro, M. Hayot, M. Voyer, A. S. Comtois, A. E. Grassino, and G. Czaika Time-based gene expression programme following diaphragm injury in a rat model Eur. Respir. J., March 1, 2005; 25(3): 422 - 430. [Abstract] [Full Text] [PDF]

				Y. Yoshiko, K. Hirao, and N. Maeda Differentiation in C2C12 myoblasts depends on the expression of endogenous IGFs and not serum depletion Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1278 - C1286. [Abstract] [Full Text] [PDF]

				M. Carrasco, J. Canicio, M. Palacin, A. Zorzano, and P. Kaliman Identification of Intracellular Signaling Pathways that Induce Myotonic Dystrophy Protein Kinase Expression during Myogenesis Endocrinology, August 1, 2002; 143(8): 3017 - 3025. [Abstract] [Full Text] [PDF]

				A. Takahashi, Y. Kureishi, J. Yang, Z. Luo, K. Guo, D. Mukhopadhyay, Y. Ivashchenko, D. Branellec, and K. Walsh Myogenic Akt Signaling Regulates Blood Vessel Recruitment during Myofiber Growth Mol. Cell. Biol., July 1, 2002; 22(13): 4803 - 4814. [Abstract] [Full Text] [PDF]

				S. Adi, B. Bin-Abbas, N.-Y. Wu, and S. M. Rosenthal Early Stimulation and Late Inhibition of Extracellular Signal-Regulated Kinase 1/2 Phosphorylation by IGF-I: A Potential Mechanism Mediating the Switch in IGF-I Action on Skeletal Muscle Cell Differentiation Endocrinology, February 1, 2002; 143(2): 511 - 516. [Abstract] [Full Text] [PDF]

				M. I. Kontaridis, X. Liu, L. Zhang, and A. M. Bennett SHP-2 complex formation with the SHP-2 substrate-1 during C2C12 myogenesis J. Cell Sci., January 6, 2001; 114(11): 2187 - 2198. [Abstract] [Full Text] [PDF]

				M. A. Lawlor and P. Rotwein Insulin-Like Growth Factor-Mediated Muscle Cell Survival: Central Roles for Akt and Cyclin-Dependent Kinase Inhibitor p21 Mol. Cell. Biol., December 1, 2000; 20(23): 8983 - 8995. [Abstract] [Full Text]

				U. Delling, J. Tureckova, H. W. Lim, L. J. De Windt, P. Rotwein, and J. D. Molkentin A Calcineurin-NFATc3-Dependent Pathway Regulates Skeletal Muscle Differentiation and Slow Myosin Heavy-Chain Expression Mol. Cell. Biol., September 1, 2000; 20(17): 6600 - 6611. [Abstract] [Full Text]

				T. Merkulova, A. Keller, P. Oliviero, F. Marotte, J.-L. Samuel, L. Rappaport, N. Lamande, and M. Lucas Thyroid hormones differentially modulate enolase isozymes during rat skeletal and cardiac muscle development Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E330 - E339. [Abstract] [Full Text] [PDF]

				Y. Fujio, K. Guo, T. Mano, Y. Mitsuuchi, J. R. Testa, and K. Walsh Cell Cycle Withdrawal Promotes Myogenic Induction of Akt, a Positive Modulator of Myocyte Survival Mol. Cell. Biol., July 1, 1999; 19(7): 5073 - 5082. [Abstract] [Full Text] [PDF]

				P. Kaliman, J. Canicio, X. Testar, M. Palacin, and A. Zorzano Insulin-like Growth Factor-II, Phosphatidylinositol 3-Kinase, Nuclear Factor-kappa B and Inducible Nitric-oxide Synthase Define a Common Myogenic Signaling Pathway J. Biol. Chem., June 18, 1999; 274(25): 17437 - 17444. [Abstract] [Full Text] [PDF]

				A. Musaro and N. Rosenthal Maturation of the Myogenic Program Is Induced by Postmitotic Expression of Insulin-Like Growth Factor I Mol. Cell. Biol., April 1, 1999; 19(4): 3115 - 3124. [Abstract] [Full Text] [PDF]

				D. D. Sarbassov and C. A. Peterson Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase Regulate Extracellular Signal-Regulated Kinase-Dependent and -Independent Signaling Pathways during Myogenic Differentiation Mol. Endocrinol., December 1, 1998; 12(12): 1870 - 1878. [Abstract] [Full Text]

				J. Canicio, E. Gallardo, I. Illa, X. Testar, M. Palacin, A. Zorzano, and P. Kaliman p70 S6 Kinase Activation Is Not Required for Insulin-Like Growth Factor-Induced Differentiation of Rat, Mouse, or Human Skeletal Muscle Cells Endocrinology, December 1, 1998; 139(12): 5042 - 5049. [Abstract] [Full Text] [PDF]

				P. Kaliman, J. Canicio, P. R. Shepherd, C. A. Beeton, X. Testar, M. Palacín, and A. Zorzano Insulin-like Growth Factors Require Phosphatidylinositol 3-Kinase to Signal Myogenesis: Dominant Negative p85 Expression Blocks Differentiation of L6E9 Muscle Cells Mol. Endocrinol., January 1, 1998; 12(1): 66 - 77. [Abstract] [Full Text]

				C. E. H. Stewart and P. Rotwein Insulin-like Growth Factor-II Is an Autocrine Survival Factor for Differentiating Myoblasts J. Biol. Chem., May 10, 1996; 271(19): 11330 - 11338. [Abstract] [Full Text] [PDF]

				D. Montarras, F. Aurade, T. Johnson, J. IIan, F. Gros, and C. Pinset Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage J. Cell Sci., March 1, 1996; 109(3): 551 - 560. [Abstract] [PDF]

				L. L. Tortorella, D. J. Milasincic, and P. F. Pilch Critical Proliferation-independent Window for Basic Fibroblast Growth Factor Repression of Myogenesis via the p42/p44 MAPK Signaling Pathway J. Biol. Chem., April 20, 2001; 276(17): 13709 - 13717. [Abstract] [Full Text] [PDF]